Systematic Review: Barriers That Prevent Compliance With Hydroxyurea in Sickle Cell Disease
Sickle cell disease (SCD) is a blood disorder that is inherited from both parents and affects millions of people globally. The symptoms of SCD may be debilitating and pose a significant challenge to nursing care. Hydroxyurea (HU), the Food and Drug Administration (FDA) approved treatment for SCD in...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | en |
| Published: |
ScholarWorks
2016
|
| Subjects: | |
| Online Access: | https://scholarworks.waldenu.edu/dissertations/2985 https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=4088&context=dissertations |